These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24326545)

  • 1. The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders.
    Waldmann TA
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S28-30. PubMed ID: 24326545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.
    Liu LY; King BA
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S18-S20. PubMed ID: 29273099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
    Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
    J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation.
    Perdreau H; Mortier E; Bouchaud G; Solé V; Boublik Y; Plet A; Jacques Y
    Eur Cytokine Netw; 2010 Dec; 21(4):297-307. PubMed ID: 21078585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
    Cheng MW; Kehl A; Worswick S; Goh C
    J Drugs Dermatol; 2018 Jul; 17(7):800-803. PubMed ID: 30005104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
    Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
    J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
    Mrowietz U; Gerdes S; Gläser R; Schröder O
    Acta Derm Venereol; 2017 Feb; 97(2):283-284. PubMed ID: 27349217
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic development in psoriasis.
    Sobell JM; Leonardi CL
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S69-72. PubMed ID: 25268599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients.
    Liu LY; Craiglow BG; King BA
    J Am Acad Dermatol; 2018 Feb; 78(2):403-404.e1. PubMed ID: 29108908
    [No Abstract]   [Full Text] [Related]  

  • 11. The IL-2/IL-15 receptor systems: targets for immunotherapy.
    Waldmann TA
    J Clin Immunol; 2002 Mar; 22(2):51-6. PubMed ID: 11998892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.
    Waldmann TA; Tagaya Y
    Annu Rev Immunol; 1999; 17():19-49. PubMed ID: 10358752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.
    Tanaka Y; Yamaoka K
    Mod Rheumatol; 2013 May; 23(3):415-24. PubMed ID: 23212593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
    Xing L; Dai Z; Jabbari A; Cerise JE; Higgins CA; Gong W; de Jong A; Harel S; DeStefano GM; Rothman L; Singh P; Petukhova L; Mackay-Wiggan J; Christiano AM; Clynes R
    Nat Med; 2014 Sep; 20(9):1043-9. PubMed ID: 25129481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Good and Bad News About New Drugs for Treating Alopecia Areata.
    Morgado-Carrasco D; Rodríguez-Lobato E; Riera-Monroig J; Ferrando J
    Actas Dermosifiliogr (Engl Ed); 2018; 109(1):69-70. PubMed ID: 28641742
    [No Abstract]   [Full Text] [Related]  

  • 16. Tofacitinib therapy for children with severe alopecia areata.
    Dai YX; Chen CC
    J Am Acad Dermatol; 2019 Apr; 80(4):1164-1166. PubMed ID: 30630026
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα.
    Chen J; Feigenbaum L; Awasthi P; Butcher DO; Anver MR; Golubeva YG; Bamford R; Zhang X; St Claire MB; Thomas CJ; Discepolo V; Jabri B; Waldmann TA
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13534-9. PubMed ID: 23904478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation.
    Olsen SK; Ota N; Kishishita S; Kukimoto-Niino M; Murayama K; Uchiyama H; Toyama M; Terada T; Shirouzu M; Kanagawa O; Yokoyama S
    J Biol Chem; 2007 Dec; 282(51):37191-204. PubMed ID: 17947230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tofacitinib in treatment of alopecia areata.
    Ferreira SB; Ferreira RB; Scheinberg MA
    Einstein (Sao Paulo); 2020; 18():eAI5452. PubMed ID: 32785452
    [No Abstract]   [Full Text] [Related]  

  • 20. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases.
    Waldmann T
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S161-7. PubMed ID: 12110135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.